VISENTIN, ANDREA

VISENTIN, ANDREA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 150 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases 2022 Evangelista, LauraCrimi', FilippoVisentin, AndreaVoltan, GiacomoTrentin, LivioCecchin, DiegoCeccato, Filippo + CURRENT ONCOLOGY - -
A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection 2022 Cellini A.Visentin A.Vedovato S.Marinello S.Trentin L.Gurrieri C. + APPLIED SCIENCES - -
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib 2020 Scapinello, GretaRiva, MarcelloPizzi, MarcoManni, SabrinaVisentin, AndreaTrentin, LivioSemenzato, GianpietroPiazza, Francesco + ANNALS OF HEMATOLOGY - -
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 2024 Sommaggio, RobertaCappuzzello, ElisaCatanzaro, DanielaChieregato, KatiaMerlo, AnnaPieta, Anna DallaTrentin, LivioVisentin, AndreaRosato, Antonio + HAEMATOLOGICA - -
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency 2022 Visentin, AndreaPravato, StefanoCellini, AlessandroAngotzi, FrancescoCavarretta, Chiara AdeleRuocco, ValeriaPiazza, FrancescoTrentin, Livio + CURRENT ONCOLOGY - -
A SCORING SYSTEM TO PREDICT THE RISK OF ATRIAL FIBRILLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA 2019 Visentin, APiazza, FSemenzato, GTrentin, L + HEMATOLOGICAL ONCOLOGY - -
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 2017 Pizzi, MarcoGaluppini, FrancescaFassan, MatteoVisentin, AndreaPiazza, FrancescoSemenzato, Gianpietro CRugge, Massimo + HISTOPATHOLOGY - -
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 2018 Martini, VeronicaFrezzato, FedericaSeverin, FilippoRaggi, FlaviaTrimarco, ValentinaVisentin, AndreaFacco, MonicaSemenzato, GianpietroTrentin, Livio + ONCOTARGET - -
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 2017 Zaja, FrancescoVisentin, Andrea + AMERICAN JOURNAL OF HEMATOLOGY - -
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes 2022 Cavarretta, Chiara AdeleVisentin, AndreaPravato, StefanoPiazza, FrancescoBasso, DanielaTrentin, Livio + INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY - -
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 2017 Ruggero, S.Ermani, M.Campagnolo, M.Salvalaggio, A.De Michelis, C.Visentin, A.RUIZ, MARTABriani, C. + EUROPEAN JOURNAL OF NEUROLOGY - -
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 2023 Visentin, AndreaTrentin, Livio + CANCERS - -
Assessment of the 4-factor score: retrospective analysis of 586 cll patients receiving ibrutinib. A campus cll study 2021 Visentin, AndreaTrentin, Livio + AMERICAN JOURNAL OF HEMATOLOGY - -
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 2012 TRIMARCO, VALENTINAFREZZATO, FEDERICAGATTAZZO, CRISTINAMARTINI, VERONICAVISENTIN, ANDREAAVE, ELISACASTELLI, MONICAFACCO, MONICASEMENZATO, GIANPIETRO CARLOTRENTIN, LIVIO + HAEMATOLOGICA - -
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 2019 Visentin, AndreaImbergamo, SilviaSCOMAZZON, EDOARDOPRAVATO, STEFANOFrezzato, FedericaPizzi, MarcoVio, StefaniaGREGIANIN, MICHELEBurei, MartaFacco, MonicaSemenzato, GianpietroPiazza, FrancescoTrentin, Livio + BRITISH JOURNAL OF HAEMATOLOGY - -
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 2017 Visentin, AndreaImbergamo, SilviaFrezzato, FedericaPizzi, MarcoBertorelle, RobertaScomazzon, EdoardoBerno, TamaraRiva, MarcelloPiva, ElisaFacco, MonicaPiazza, FrancescoSemenzato, GianpietroTrentin, Livio ONCOTARGET - -
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study 2016 ZAJA, FRANCESCOZambello, RenatoVisentin, Andrea + ANNALS OF HEMATOLOGY - -
Bleomycin-induced flagellate dermatitis in a patient with Hodgkin lymphoma 2023 Piazza, FrancescoTrentin, LivioVisentin, Andrea + MEDICINA CLINICA - -
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients 2019 RIVA, MARCELLOLessi, FedericaVisentin, AndreaCampagnolo, MartaSemenzato, GianpietroAdami, FaustoBriani, Chiara + LEUKEMIA & LYMPHOMA - -
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: a Fondazione Italiana Linfomi real-life experience 2021 Visentin, Andrea + HEMATOLOGICAL ONCOLOGY - -